SCYNEXIS (SCYX)
(Delayed Data from NSDQ)
$1.55 USD
+0.09 (6.16%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.56 +0.01 (0.65%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for SCYNEXIS, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 75 | 74 | 104 | 93 | 48 |
Receivables | 0 | 2 | 1 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 1 | 0 | 0 | 0 |
Other Current Assets | 27 | 3 | 4 | 5 | 4 |
Total Current Assets | 102 | 79 | 109 | 98 | 52 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 24 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 1 | 0 | 0 |
Deposits & Other Assets | 0 | 6 | 6 | 1 | 1 |
Total Assets | 128 | 88 | 120 | 103 | 57 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 6 | 8 | 5 | 7 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 8 | 6 | 6 | 4 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 6 | 0 | 18 | 0 |
Total Current Liabilities | 16 | 18 | 14 | 26 | 11 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3 | 0 | 0 | 0 | 0 |
Convertible Debt | 12 | 11 | 12 | 17 | 12 |
Long-Term Debt | 0 | 34 | 29 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 22 | 19 | 21 | 34 | 18 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 55 | 85 | 79 | 80 | 44 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 428 | 425 | 401 | 349 | 284 |
Retained Earnings | -355 | -422 | -359 | -327 | -271 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 73 | 3 | 41 | 23 | 13 |
Total Liabilities & Shareholder's Equity | 128 | 88 | 120 | 103 | 57 |
Total Common Equity | 73 | 3 | 41 | 23 | 13 |
Shares Outstanding | 37.20 | 32.60 | 23.90 | 19.60 | 9.70 |
Book Value Per Share | 1.96 | 0.10 | 1.73 | 1.16 | 1.33 |
Fiscal Year End for SCYNEXIS, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 75 | 88 | 86 | 55 |
Receivables | NA | 0 | 2 | 2 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 13 | 10 | 1 |
Other Current Assets | NA | 27 | 25 | 47 | 2 |
Total Current Assets | NA | 102 | 129 | 146 | 60 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 24 | 17 | 6 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 8 |
Total Assets | NA | 128 | 149 | 155 | 70 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 7 | 3 | 3 | 6 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 35 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 8 | 10 | 7 | 5 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 3 | 5 | 0 |
Total Current Liabilities | NA | 16 | 17 | 16 | 46 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 3 | 2 | 1 | 0 |
Convertible Debt | NA | 12 | 12 | 12 | 11 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 24 | 30 | 40 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 55 | 57 | 62 | 100 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 428 | 428 | 427 | 426 |
Retained Earnings | NA | -355 | -336 | -334 | -456 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 73 | 92 | 93 | -30 |
Total Liabilities & Shareholder's Equity | NA | 128 | 149 | 155 | 70 |
Total Common Equity | 0 | 73 | 92 | 93 | -30 |
Shares Outstanding | 37.70 | 37.20 | 37.10 | 36.50 | 36.50 |
Book Value Per Share | 0.00 | 1.96 | 2.48 | 2.55 | -0.82 |